Navigation Links
New drug for breast cancer prevention produced by Arimidex

The number of breast cancer cases has reached about 1.2 million worldwide and Statistics show that the incidence of breast cancer is rapidly increasing in urban India and has overtaken cancer of the cervix as the number one cancer // in our major metros according to a study conducted on women and cancer in India. Oil foods, obesity, smoking, drinking, late marriage and delayed motherhood are some factors that can lead to a high risk of breast cancer.

The new drug that is being manufactured by the pharmaceutical company Arimidex is said to prevent occurrence of recurrence of breast cancer after surgery. Arimidex claims that its new drug is 26% more effective than the current drugs in preventing breast cancer recurrence. The Breast Cancer Care Scotland his very happy and it expressed that it will be helpful for women in Scotland with breast cancer. The new drug, which has been approved by Scottish Medicines Consortium, is yet to get approved for general use in England. The new drug will be very helpful for all post-menopausal women with early breast cancer as the drug has to be taken after surgery and it significantly reduces the occurrence of recurrence breast cancer.

Leading breast cancer surgeon Dr Chris Wilson, of Glasgow's Western Infirmary, said:
'"/>




Page: 1

Related medicine news :

1. Ductal lavage may detect early breast cancer
2. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
3. Micro-camera provides new breast imaging technique
4. Support therapy helps breast cancer patients
5. Variation in breast cancer
6. Appropriate treatment for breast cancer
7. Combination therapy to treat breast cancer
8. Hope for breast cancer patients
9. Pregnancy weight linked to breast cancer
10. New breast cancer genes discovered
11. New breast cancer drug appears encouraging
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... 24, 2017 , ... Healthcare Associates of McKinney announced today that ... at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in ... , As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... Charlevoix, MI (PRWEB) , ... February 24, 2017 ... ... venue in Charlevoix, once again hosted their Military Wedding Giveaway, with the ... be hosted by Castle Farms with services generously donated from local vendors: A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare ... audience, will be participating in Rare Disease Day events, hosted by the Rare ... Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an approved content provider for the National Institute for Health and Care ... social care-related organizations in the National Health Service (NHS) to search, order and ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... ITL Limited, ( ASX: ITD ), an innovative diversified ... year ended 31 December 2016 compared with the previous corresponding period. ... viewed here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: ... 2015: $15.7m; up 11%) Profit before tax of ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: